Back to search results
NCT06661031

Developing a Telehealth + mHealth Cannabis Use Intervention for Young Adults

Enrolling by Invitation
NAAges 18–26InterventionalTreatment
Boston Children's Hospital
~65 participants
Updated 2026-08-03 on ClinicalTrials.gov
What's tested:Motivational Enhancement Therapy plus Ecological Momentary InterventionEnhanced Usual Care

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Intervention completion
Measured over At week 3 (Upon completion of 2-week EMI period)
+10 more outcomes measured

Conditions

Cannabis Use Disorder

Explore related trials

Cannabis Use Disorder

Where it's being run

1 sites across 1 states
Massachusetts1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Primary care patient of the Boston Children's Hospital Adolescent/Young Adult Medicine Practice
Participation in MOMENT-V open pilot
Ownership of a smartphone
Availability for the 2-week study duration
Primary care patient of the Boston Children's Hospital Adolescent/Young Adult Medicine Practice or Martha Eliot Health Center Adolescent Clinic
18 to 26 years old
Cannabis Use Disorders Identification Test-Revised (CUDIT-R) score of ≥8
Recreational cannabis use on \>3 days/week, on average, in the past 30 days
Ownership of a smartphone that is PIN- or password-protected
Ability to read and speak English
Availability for the 6-month study duration

Exclusion

Inability/Unwillingness to provide contact information
Current pregnancy or parenting
Inability/Unwillingness to provide contact information
Written certification from a physician for marijuana for medical use
Current participation in a substance use treatment program or research study
Current pregnancy or parenting
Participation in prior MOMENT or MOMENT-V research

What this trial measures

  • Intervention completionAt week 3 (Upon completion of 2-week EMI period)

    \[Aim 1\] Percent of participants assigned to the intervention arm completing the intervention (defined as both MET sessions and any EMI surveys). Benchmark: ≥80%

  • EMI engagementIn weeks 1-3 (during 2-week EMI period)

    \[Aim 1\] Percent of days on which participant responded to at least one survey during the 14 days of EMI. Benchmark: Median of ≥80% across intervention participants

  • Acceptability: Overall satisfactionAt 6-month timepoint

    \[Aim 1\] Satisfaction with intervention measured on the Client Satisfaction Questionnaire-8, an 8-item 4-point scale on which scores range from 8-32, with higher scores indicating greater satisfaction. Benchmark: ≥80% of participants with a scale score ≥24 (mean item score of ≥3 out 4)

  • Acceptability: ComponentsAt week 0, week 1, and week 3

    \[Aim 1\] Measure of acceptability (usability, likability, perceived effect, burden) for each intervention component (2 MET sessions and EMI). Components assessed with an 11- or 12-item 5-point Likert-type scales (1, Strongly Disagree to 5, Strongly Agree) developed for the study. Higher scores indicate greater acceptability. Benchmark for each scale: ≥80% of participants with mean item score ≥4 out of 5

  • ScreeningDuring recruitment (upon completion of eligibility survey: pre-enrollment, pre-Baseline)

    \[Aim 2\] Number of patients self-screening per month. Benchmark: ≥13 per month

  • EligibilityDuring recruitment (upon completion of eligibility survey: pre-enrollment, pre-Baseline)

    \[Aim 2\] Number of patients eligible per month. Benchmark: ≥6 per month

  • EnrollmentUpon enrollment

    \[Aim 2\] Number of patients enrolled per month. Benchmark: ≥3 per month

  • Retention in trialAt 3-week timepoint, 3-month timepoint, 6-month timepoint

    \[Aim 2\] Percent of participants retained at each assessment time point (3 weeks, 3 months, 6 months, by assigned condition. Benchmark: ≥80% at each time point

  • Days of cannabis useAt Baseline, 3-week timepoint, 3-month timepoint, 6-month timepoint

    \[Aim 3\] Number of cannabis use days measured on Timeline Follow-Back (TLFB) calendar

  • Times of cannabis useAt Baseline, 3-week timepoint, 3-month timepoint, 6-month timepoint

    \[Aim 3\] Number of cannabis use times measured on TLFB calendar

  • Negative consequences of cannabis useAt Baseline, 3-month timepoint, 6-month timepoint

    \[Aim 3\] Number of negative consequences (problems) measured on the 19-item Marijuana Problems Scale